This study is in progress, not accepting new patients
Study to Gather Information on Safety and Use of High Dose Aflibercept Injection Into the Eye in Patients With an Age Related Eye Disorder That Causes Blurred Vision or a Blind Spot Due to Abnormal Blood Vessels That Leak Fluid Into the Light Sensitive Lining Inside the Eye
Summary
- Eligibility
- for people ages 50 years and up (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Bayer
- ID
- NCT04423718
- Phase
- Phase 3 Macular Degeneration Research Study
- Study Type
- Interventional
- Participants
- At least 1016 people participating
- Last Updated